Characterization of a Partially Deleted Heavy-Chain Gene and Its Protein Product Synthesized In Vivo and In Vitro

Objective. A patient presented with heavy-chain deposition disease (HCDD), exhibiting severe erosive polyarthropathy caused by synovial deposits of abnormal monoclonal, heavily deleted free 3 heavy chains lacking the VH and CH1 domains. The absence of VH was surprising, since it is considered important for pathogenic tissue deposition. This study was undertaken to analyze the genetic structure of the heavy chain, the protein product synthesized in vitro, and that deposited in the synovium in comparison with the serum and urinary proteins. Methods. Hybridomas were made by fusion of blood and bone marrow mononuclear cells with mouse myeloma cells. Cloned B cell hybridomas secreting 3 were selected and analyzed by polymerase chain reaction. Purified hybridoma Ig was sequenced by Edman degradation. Antiserum raised to a peptide corresponding to residues 2–15 of the truncated VH was used in Western blots of synovial tissue. Results. The hybridomas secreted free 3 chains consisting of a VH4 gene truncated 21 nucleotides into the first complementarity-determining region and then reading straight into the hinge region. The amino acid sequence confirmed the presence of residues 1–32 of the VH4 gene. Immunoblotting of synovial tissue showed the presence of Ig with truncated VH. Conclusion. The 3 heavy chain had a deletion of VH from codon 33 and of the entire CH1. In vivo, the 32 VH amino acids were proteolytically degraded. In the joint, however, the 32 residues of VH remained intact, consistent with a pathogenic role of V H for tissue deposition. To our knowledge, this is the first reported case of HCDD causing an erosive, polyarticular arthropathy as the dominating clinical feature.

[1]  J. Salmon,et al.  Human receptors for immunoglobulin G: key elements in the pathogenesis of rheumatic disease. , 2001, Arthritis and rheumatism.

[2]  G. Panayi,et al.  Cytokine pathways and joint inflammation in rheumatoid arthritis. , 2001, The New England journal of medicine.

[3]  J. Buxbaum Abnormal immunoglobulin synthesis in monoclonal immunoglobulin light chain and light and heavy chain deposition disease , 2001, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[4]  Gaarder,et al.  The Amino Acid Sequence of a Monoclonal γ3‐Heavy Chain from a Patient with Articular γ‐Heavy Chain Deposition Disease , 2000, Scandinavian journal of immunology.

[5]  K. Anumula,et al.  High-yield deblocking of amino termini of recombinant immunoglobulins with pyroglutamate aminopeptidase. , 1998, Analytical biochemistry.

[6]  J. Chomilier,et al.  Molecular modeling of immunoglobulin light chains implicates hydrophobic residues in non-amyloid light chain deposition disease. , 1997, Protein engineering.

[7]  A. Khamlichi,et al.  Structure of abnormal heavy chains in human heavy-chain-deposition disease. , 1995, European journal of biochemistry.

[8]  A. Solomon,et al.  Primary amyloidosis associated with a novel heavy‐chain fragment (AH amyloidosis) , 1994, American journal of hematology.

[9]  B. Chauffert,et al.  Heavy-Chain Deposition Disease , 1993 .

[10]  J. Brouet,et al.  Gamma Heavy Chain “Disease”: Heterogeneity of the Clinicopathologic Features Report of 16 Cases and Review of the Literature , 1989, Medicine.

[11]  J. Buxbaum,et al.  Gamma heavy chain disease in man. Genomic sequence reveals two noncontiguous deletions in a single gene. , 1988, The Journal of clinical investigation.

[12]  D. Hough,et al.  The efficient production of stable, human monoclonal antibody-secreting hybridomas from EBV-transformed lymphocytes using the mouse myeloma X63-Ag8.653 as a fusion partner. , 1986, Journal of immunological methods.

[13]  L. Hood,et al.  gamma Heavy chain disease in man: cDNA sequence supports partial gene deletion model. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[14]  J. Buxbaum,et al.  Gamma heavy chain disease in man: translation and partial purification of mRNA coding for the deleted protein. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[15]  B. Frangione,et al.  Repetitive hinge region sequences in human IgG3: isolation of an 11,000-dalton fragment. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[16]  K. Sletten,et al.  Chronic arthritis and gamma heavy chain disease: coincidence or pathogenic link? , 1998, Scandinavian journal of rheumatology.

[17]  Marie-Paule Lefranc,et al.  IMGT, the international ImMunoGeneTics database , 2001, Nucleic Acids Res..